Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Analytical Food Chemistry at Technical University of Munich | Freising, Bayern | Germany | about 1 month ago
) and fourteen associated partners including six from industry and two start-ups. For more information, please have a look at https://microsunset.dtu.dk/ . To be eligible for a MICROSUNSET PhD
-
for the OPUS 28 call: https://ncn.gov.pl/sites/default/files/pliki/uchwaly-rady/2024/uchwala84_2024-zal1.pdf The candidate should: Know the physiology of the nervous system, molecular and cell biology
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 1 month ago
of Porto, at Salomé Pinho´s lab. Scientific Area: Immunology, Biochemistry, Glycobiology, Carbohydrates, Biophysics 1. Project summary and work plan GLYCOCALYX (https://www.glycocalyx.org/ ) brings together
-
spatial resolution. AT ISTA, we pursue a broad range of studies in electrophysiology (Jonas , Csicsvari , and Shigemoto ) and imaging (Joesch , Danzl and Douglass ), in both in vitro slice preparations and
-
of histomorphological cancer phenotypes using self-supervised learning on unlabeled, unannotated pathology slides. arXiv. 2023 Albert-László Barabási. Network Science. Cambridge University Press. 2016. http
-
studies leading to the PhD degree or in a non-degree course. - Have experience in molecular biology assays, recombinant DNA and RNA production, microscopy, and in vitro assays with cancer cell lines. BIs
-
biological matrices. Hands-on acquisition of SERS data from biologically and clinically relevant samples, including in vitro bacterial cultures, experimentally infected wound models, and clinical wound samples
-
. The researcher will perform in vitro experiments using standard cell culture techniques and carry out basic molecular analyses (e.g., gene and protein expression studies). It will also participate in
-
by identifying and validating therapeutic targets for treatment and by developing robust protocols for in vitro production of clinical-grade blood cells for adoptive cancer immunotherapies
-
, antigen presentation and trained immunity) using mouse models that enable CPT1A gain or loss of function. Furthermore, the bioenergetic profile of macrophages both in vitro and ex vivo will be assessed